Filtered By:
Management: Marketing
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 200 results found since Jan 2013.
Balancing Burdens and Benefits: Ethical Issues of Off-Label Prescription Pharmaceutical Use
I remember when Botox (Allergen, Irvine, CA) was becoming all the rage in rehabilitation in the mid 1990s. As I recall, the only U.S. Food and Drug Administration (FDA) approved uses at the time were for spasmodic torticollis and blepharospasm. In a short period of time, however, Botox was the new treatment du jour for adults and children alike with spasticity from CP, traumatic brain injury (TBI), and stroke. I also remember feeling a bit queasy about it. Perhaps having recently completed a fellowship in clinical medical ethics colored my view. Images of thousands of people with limb deficiencies, the tragic consequence ...
Source: PM and R - October 1, 2013 Category: Rehabilitation Authors: Ford Vox, Alexander M. Capron, Marilyn F. Kraus, G. Caleb Alexander, Kristi L. Kirschner Tags: Ethical Legal Source Type: research
Cranberries Are a Smart Choice for Your Brain
Eating cranberries is good for the health of your brain. Here's the scoop on how they may help ward off Alzheimer's disease or reduce the brain damage after a stroke.read more
Source: Psychology Today Food and Diet Center - November 11, 2013 Category: Nutrition Authors: Linda Wasmer Andrews Tags: Diet Health Alzheimer’s disease antioxidant Catherine Neto cranberries cranberry extract cranberry juice Cranberry Marketing Committee cranberry sauce domoic acid excitotoxicity food Memory neurodegenerative disorder nutrit Source Type: news
Tyrosine Pharma Names Laslie President and CEO
ALBUQUERQUE, N.M.--(Healthcare Sales & Marketing Network)--Tyrosine Pharma, Inc., has announced the appointment of Wayne Laslie as president and chief executive officer. Tyrosine Pharma is a New Mexico-based biotech company that is developing a treatment f... Biopharmaceuticals, Neurology, PersonnelTyrosine Pharma, stroke
Source: HSMN NewsFeed - December 5, 2013 Category: Pharmaceuticals Source Type: news
Ornim Medical Announces New Study Results Demonstrating the Value of the CerOx(TM) Cerebral Oxygen Monitor in the Treatment of Patients With Severe Traumatic Brain Injury
Healthcare Professionals Can Learn More About Ornim's Groundbreaking Technology at the International Stroke Conference From February 12-14, 2014, in San Diego
KFAR SABA, ISRAEL--(Healthcare Sales & Marketing Network) - Ornim Medical, Inc., a biomedical ... Devices, Monitoring, NeurosurgeryOrnim Medical, CerOx, cerebral oxygen, traumatic brain injury
Source: HSMN NewsFeed - February 13, 2014 Category: Pharmaceuticals Source Type: news
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
A significant addition that complements the company's innovative suite of diagnostics and services, Boston Heart's MPO is easy for clinicians to use and FDA-cleared.
FRAMINGHAM, Mass., March 6, 2014 -- (Healthcare Sales & Marketing Network) -- Boston H... Diagnostics, Cardiology, Product LaunchBoston Heart Diagnostics, myeloperoxidase, MPO test, heart attack
Source: HSMN NewsFeed - March 6, 2014 Category: Pharmaceuticals Source Type: news
Poker, marketing strategies might help doctors think better
Stroke doctors might be wise to think about poker players and marketers before making medical decisions, according to an article. "Sadly, more research has gone into how decisions are made when people gamble or buy a car than it has to discovering how doctors make complex decisions," said the lead author. "I think if doctors better understand a poker player's betting strategy or the psychology behind a salesman's tactics, it might change their decision-making process. Doctors might be more encouraged to use tools that would help them make quick, accurate, unbiased decisions when facing difficult clinical scenarios."
Source: ScienceDaily Headlines - May 29, 2014 Category: Science Source Type: news
Reply Regarding the Effect of Dabigatran Plasma Concentrations
We would like to respond to Dr. Rao's questions concerning our paper (1). First, it is incorrect to state that any data on dabigatran and plasma levels were suppressed. This information has been submitted to all regulatory authorities as part of the original registration process of dabigatran etexilate for reduction of stroke in patients with atrial fibrillation. These data have also been in the public domain since the U.S. Food and Drug Administration (FDA) Advisory Committee meeting in September 2010, before marketing approval (2).
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - June 23, 2014 Category: Cardiology Source Type: research
Zynex Appoints Director of Business Development
LONE TREE, CO--(Healthcare Sales & Marketing Network) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological di... Devices, PersonnelZynex, NeuroDiagnostics
Source: HSMN NewsFeed - June 25, 2014 Category: Pharmaceuticals Source Type: news
Keeping the Genie in the Bottle Growth Hormone and Cardiovascular Disease ∗
Anabolic hormone use is increasingly common and includes replacement in patients with hormone deficiencies, questionable uses in those with borderline-low levels, and clear abuses among athletes aiming to gain a competitive advantage. Recently, direct-to-consumer marketing touting the benefits of “low T” treatment has led to increased testosterone use among middle-aged and older men, despite inadequate cardiovascular safety data. Although the Testosterone in Older Men Trial showed improvements in strength among treated patients, it was prematurely halted due to increased cardiovascular events in the treatment arm (1). ...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - September 29, 2014 Category: Cardiology Source Type: research
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Randomized Controlled SENTINEL Trial is the First in the U.S. to Study Capture and Removal of Debris Released During TAVR That May Otherwise Be the Source of Stroke
SANTA ROSA, Calif.--(Healthcare Sales & Marketing Network)--Claret Medical, Inc., a deve... Devices, Interventional CardiologyClaret Medical, Cerebral Protection, TAVR, transcatheter, aortic valve
Source: HSMN NewsFeed - October 6, 2014 Category: Pharmaceuticals Source Type: news
OPINION: Now Is the Time to Tackle Malnutrition and Its Massive Human Costs
Sadhana Ghimire, 23, makes sure to give her 18-month-old daughter nutritious food, such as porridge containing grains and pulses, in order to prevent stunting. Credit: Mallika Aryal/IPSBy José Graziano da Silva and Margaret ChanROME/GENEVA, Nov 13 2014 (IPS)The scourge of malnutrition affects the most vulnerable in society, and it hurts most in the earliest stages of life. Today, more than 800 million people are chronically hungry, about 11 percent of the global population.Undernutrition is the underlying cause of almost half of all child deaths, and a quarter of living children are stunted due to inadequate nutrition. Mi...
Source: IPS Inter Press Service - Health - November 13, 2014 Category: Global & Universal Authors: Jose Graziano da Silva and Margaret Chan Tags: Advancing Deserts Biodiversity Climate Change Development & Aid Economy & Trade Environment Food & Agriculture Global Global Governance Headlines Health IPS UN: Inside the Glasshouse Population Poverty & MDGs TerraViva United N Source Type: news
FDA clears system to reduce stroke risk during stent and angioplasty procedures
The U.S. Food and Drug Administration today cleared for marketing the ENROUTE Transcarotid Neuroprotection System (ENROUTE TNS), for use during a minimally invasive procedure to restore normal blood flow to narrowed carotid arteries. It is the first device designed to access the carotid arteries through an incision in the neck, instead of the groin, and uses a blood flow reversal system to capture pieces of the blockage dislodged during the procedure.
Source: Food and Drug Administration - February 9, 2015 Category: American Health Source Type: news
Silk Road Medical Announces FDA 510(k) Clearance of the ENROUTE(R) Transcarotid Neuroprotection System
Novel system to protect against stroke via direct carotid access and robust blood flow reversal initiates a new era in carotid revascularization
SUNNYVALE, Calif., Feb. 10, 2015 -- (Healthcare Sales & Marketing Network) -- Silk Road Medical, Inc., a pi... Devices, Interventional, FDASilk Road Medical, Transcarotid Neuroprotection System, carotid stent
Source: HSMN NewsFeed - February 10, 2015 Category: Pharmaceuticals Source Type: news
Boston Scientific Receives FDA Approval for WATCHMAN(TM) Left Atrial Appendage Closure Device
First-Of-Its-Kind Alternative to Long-Term Warfarin Therapy for Stroke Risk Reduction in Patients with Non-Valvular Atrial Fibrillation
MARLBOROUGH, Mass., March 13, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE:... Devices, Cardiology, FDABoston Scientific, WATCHMAN Device, Left Atrial Appendage Closure Device
Source: HSMN NewsFeed - March 16, 2015 Category: Pharmaceuticals Source Type: news
Smoking Rates Are Down, But A Different Type Of Tobacco Use Is On The Rise
First, the good news: Smoking rates are down significantly in 26 states. The bad news? The use of smokeless tobacco (also known as dip, snuff or chew) is up in four states, while using both cigarettes and smokeless tobacco is up significantly in five states.
“Although overall cigarette smoking prevalence has declined significantly in recent years in many states, the overall use of smokeless tobacco and concurrent cigarette and smokeless tobacco has remained unchanged in most states and increased in some states,” summed up researchers for the Centers for Disease Control, which published the data in their weekly Morbid...
Source: Science - The Huffington Post - May 22, 2015 Category: Science Source Type: news
